6-38175136-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001099272.2(BTBD9):c.1688A>T(p.Gln563Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001099272.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BTBD9 | NM_001099272.2 | c.1688A>T | p.Gln563Leu | missense_variant | 11/11 | ENST00000481247.6 | NP_001092742.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BTBD9 | ENST00000481247.6 | c.1688A>T | p.Gln563Leu | missense_variant | 11/11 | 5 | NM_001099272.2 | ENSP00000418751.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000441 AC: 11AN: 249526Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135392
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461802Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727200
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 04, 2024 | The c.1688A>T (p.Q563L) alteration is located in exon 12 (coding exon 10) of the BTBD9 gene. This alteration results from a A to T substitution at nucleotide position 1688, causing the glutamine (Q) at amino acid position 563 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at